Question

qual a diferença entre proto-oncogenes e genes supressores de tumor ?​

Answer 1

Resposta:

os oncogenes resultam da ativação de proto-oncogenes, enquanto que os genes supressores do tumor provocam câncer quando eles são inativados.

Answer 2

Resposta:

• Preclinical to Companion Diagnostic Development for Oncology

‹

• Clinical & Diagnostics

• Preclinical to Companion Diagnostic Development

• Oncomine Assays for Oncology Research

• Oncomine TCR Beta-LR Assay

• Advancing precision medicine and pediatric therapy selection: the role of NGS

• Oncomine TCR Beta-SR Assay

• Diagnostic Development

• Clinical & Translational Research

• Diagnostic Testing

• Clinical Microbiology

• Biobanking

• Precision Medicine

• Clinical Genomics

• Cell & Gene Therapy Solutions

• preclinical-companion-diagnostic-MD_FP-612x289

• preclinical-companion-diagnostics-MD_NP-266x289

• One day, the promise of precision oncology will be realized.  We’re committed to helping labs bring that day closer. From our best-in-class Ion Torrent NGS systems to our one-day Oncomine Precision Assay and curated, accessible bioinformatics, we’re doing everything we can to help labs advance a new paradigm for genomic profiling.

• Specimen-to-report NGS in a single day with two touchpoints

• Genexus-system

• Introducing the new Ion Torrent Genexus System

• First turnkey NGS system that automates specimen-to-report workflow in a single day with just two user touchpoints. In-house NGS is now more accessible than ever.

• Learn more ›

• couple

• Oncomine Solutions for Precision Oncology

• Combine your lab’s immunohistochemistry (IHC) results with timely NGS to enable a comprehensive cancer profile in a single day.

• Learn more ›

• Jose Costa video image

• Video: Accessibility to in-house NGS

Dr. Jose Costa from IPATIMUP discusses current NGS implementation challenges in clinical research labs: it’s too slow, costly, and complex.

• Watch the video to find out how the Genexus System helps overcome all of these challenges.

• Watch video ›

• Complete NGS workflow for oncology

• Ion Torrent sequencers

• Our portfolio of sequencers delivers the answers you need with highly automated workflows for ultimate ease and efficiency

• Oncomine assays

• Pursue comprehensive genomic profiling with our assays for DNA and RNA, FFPE, and liquid biopsy samples

• Oncomine informatics
• Call it informed informatics—an approach to assay design and reporting based on our collective understanding of published cancer research and data

• Advancing precision oncology

• NGS is the platform of choice for genomic profiling. The days of having to run multiple single gene tests are over. You no longer have to settle for time delays and depletion of tissue. With NGS, you can assess multiple biomarkers simultaneously in a single test for a comprehensive molecular profile, all while preserving tissue.  Visit our educational website to learn how NGS is helping advance precision oncology from research to reality.